xml version="1.0" encoding="utf-8" ?   8-K   

false00001087720001770450  0001770450   2022-02-23 2022-02-23    0001770450  xrx:XeroxCorporationMember    2022-02-23 2022-02-23  

UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION 

Washington, D.C. 20549 

FORM 

8-K 

CURRENT REPORT 

Pursuant to Section 13 or 15(d) 

of the Securities Exchange Act of 1934 

Date of Report (date of earliest event reported): February 23, 2022 

XEROX HOLDINGS CORPORATION 

XEROX CORPORATION 

(Exact name of registrant as specified in its charter) 

  [DATA_TABLE_REMOVED]

P. O. Box 4505, 201 Merritt 7 

Norwalk, Connecticut 

06851-1056 

(Address of principal executive offices) (Zip Code) 

Registrant’s telephone number, including area code: 

203-849-5216 

Not Applicable 

(Former Name or Former Address, if Changed Since Last Report) 

Check the appropriate box below if the Form 

8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): 

   ☐ 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) 

   ☐ 

Soliciting material pursuant to Rule 

14a-12 under the Exchange Act (17 CFR 

240.14a-12) 

  [DATA_TABLE_REMOVED]

  [DATA_TABLE_REMOVED]

Securities registered pursuant to Section 12(b) of the Act: 

  [DATA_TABLE_REMOVED]

Securities registered pursuant to Section 12(g) of the Act: 

None 

Indicate by check mark whether the Registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 

12b-2 of the Securities Exchange Act of 1934 

(§240.12b-2 of this chapter). ☐ 

Emerging growth company ☐ 

If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ 

Item 7.01. Regulation FD Disclosure 

On February 23, 2022, Registrant held an Investor Day conference in New York City. Attached as Exhibit 99.1 to this Report is a copy of Registrant’s press release dated February 23, 2022 regarding the Investor Day conference. The press release was issued prior to commencement of the Investor Day conference. 

The information contained in Item 7.01 of this Report and in Exhibit 99.1 to this Report shall not be deemed “filed” with the Commission for purposes of Section 18 of the Exchange Act of 1934, as amended, or other wise subject to the liability of that section. 

 Item 9.01. 

Financial Statements and Exhibits. 

(d) Exhibits. 

  [DATA_TABLE_REMOVED]

- 2 - 

SIGNATURE 

Pursuant to the requirements of the Securities Exchange Act of 1934, each registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. 

 XEROX HOLDINGS CORPORATION 

 By:   

/s/ Douglas H. Marshall 

     Name: Douglas H. Marshall 

     Title: Assistant Secretary

Date: February 23, 2022 

 XEROX CORPORATION 

 By:   

/s/ Douglas H. Marshall 

     Name: Douglas H. Marshall 

     Titles: Assistant Secretary

Date: February 23, 2022 

- 3 -